Ironwood Pharmaceuticals (IRWD) Free Cash Flow (QoQ) (2010 - 2026)
Ironwood Pharmaceuticals (IRWD) Free Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 90.13 Bn | 88.27 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.08 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.38 Bn | 18.57 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.80 Bn | 16.48 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Ironwood Pharmaceuticals | 639.91 Mn | 419.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -93.13% |
| Dec 31, 2025 | 56.73% |
| Sep 30, 2025 | 415.73% |
| Jun 30, 2025 | -175.64% |
| Mar 31, 2025 | 30.95% |
| Dec 31, 2024 | 54.16% |
| Sep 30, 2024 | -70.46% |
| Jun 30, 2024 | -25.63% |
| Mar 31, 2024 | 26.09% |
| Dec 31, 2023 | 9.91% |
| Sep 30, 2023 | -7.30% |
| Jun 30, 2023 | -56.38% |
| Mar 31, 2023 | 1.20% |
| Dec 31, 2022 | 14.75% |
| Sep 30, 2022 | 12.65% |
| Jun 30, 2022 | -4.43% |
| Mar 31, 2022 | -0.50% |
| Dec 31, 2021 | -14.15% |
| Sep 30, 2021 | 54.56% |
| Jun 30, 2021 | -34.10% |